IL1RN and prostate carcinoma: IL1RN has been studied in several cancers, including prostate carcinoma [11, 12], cervical carcinoma [13], gastric carcinoma [14], bronchogenic carcinoma [15], endometrial cancer [16], lung cancer [17], ovarian cancer [18], oral malignancies [19], leukemia [20], and other cancers.